Revita Life Sciences

Revita Life Sciences is a regenerative medicine and biotechnology company primarily focused on the development and administration of autologous stem cell therapies. The company specializes in treating complex and chronic conditions such as neurological disorders, orthopedic injuries, and degenerative diseases that have limited options in conventional medicine. Their primary therapeutic approach involves the use of bone marrow-derived and adipose-derived mesenchymal stem cells to promote tissue repair and functional recovery. Revita operates clinical research facilities and treatment centers, bridging the gap between basic stem cell research and bedside clinical application. The organization is well-known for its protocols in treating Autism Spectrum Disorder, Spinal Cord Injury, and Optic Nerve Atrophy.